Author

Juliya Hsiang

University of ChicagoORCID 0009-0001-4960-285XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Juliya Hsiang1 paper · Harvard University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alpaslan TasdoganiD· 1 shared Brandon FaubertiD· 1 shared Brianna K. ChangiD· 1 shared Christine M. BestvinaiD· 1 shared Elyse G. SchechteriD· 1 shared Hardik ShahiD· 1 shared Kristen Erika ShemaiD· 1 shared Ling CaiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alpaslan TasdoganORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 22, 2026

MCT1 activity defines an aggressive metabolic phenotype and therapeutic target in non-small cell lung cancer

Robert B Cameron, Kristen Erika Shema, Nathan Dubois…·Brandon Faubert

This study shows that MCT1-mediated lactate uptake sustains nucleotide homeostasis in NSCLC, and its inhibition enhances chemotherapy efficacy by exposing a metabolic vulnerability.

DOI 10.64898/2026.09.20.752999

humanbulk RNA-seq

𝕏 PostBluesky